Abstract
The efficacies and safeties of a 3-day, 3-dose course of azithromycin (10 mg/kg of body weight per day) and a 10-day, 30-dose course of erythromycin (40 mg/kg/day) for the treatment of acute lower respiratory tract infections in children were compared in an open randomized multicenter study. Sixty-eight of 85 evaluable patients (80%) had radiologically proven pneumonia, and 20% had bronchitis. Treatment success defined as cure or major improvement was achieved in 42 of 45 (93%) azithromycin recipients versus 36 of 40 (90%) erythromycin recipients. Adverse events were reported in 12 of 45 and 6 of 40 of the patients treated with azithromycin and erythromycin, respectively, a difference which was not statistically significant. In conclusion, a 3-day course of azithromycin is as effective as a 10-day course of erythromycin in the treatment of community-acquired lower respiratory tract infections in children, with comparable safety and acceptability profiles. This shorter treatment course might have a beneficial effect on compliance, especially in the pediatric age group.
Full Text
The Full Text of this article is available as a PDF (158.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bartlett J. G., Mundy L. M. Community-acquired pneumonia. N Engl J Med. 1995 Dec 14;333(24):1618–1624. doi: 10.1056/NEJM199512143332408. [DOI] [PubMed] [Google Scholar]
- Felstead S. J., Daniel R. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. J Int Med Res. 1991 Sep-Oct;19(5):363–372. doi: 10.1177/030006059101900502. [DOI] [PubMed] [Google Scholar]
- Greenspan S. L., Greenspan F. S., Resnick N. M., Block J. E., Friedlander A. L., Genant H. K. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am J Med. 1991 Jul;91(1):5–14. doi: 10.1016/0002-9343(91)90066-7. [DOI] [PubMed] [Google Scholar]
- Nahata M. C., Koranyi K. I., Gadgil S. D., Hilligoss D. M., Fouda H. G., Gardner M. J. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother. 1993 Feb;37(2):314–316. doi: 10.1128/aac.37.2.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez-Solares A., Pérez-Gutiérrez F., Prosperi J., Milgram E., Martin A. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections. J Antimicrob Chemother. 1993 Jun;31 (Suppl E):103–109. doi: 10.1093/jac/31.suppl_e.103. [DOI] [PubMed] [Google Scholar]
- Treadway G., Pontani D. Paediatric safety of azithromycin: worldwide experience. J Antimicrob Chemother. 1996 Jun;37 (Suppl 100):143–149. doi: 10.1093/jac/37.suppl_c.143. [DOI] [PubMed] [Google Scholar]
- Weippl G. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J Antimicrob Chemother. 1993 Jun;31 (Suppl E):95–101. doi: 10.1093/jac/31.suppl_e.95. [DOI] [PubMed] [Google Scholar]